Telehealth platform American Well has raised $291m of a planned $315m round, the investors including strategic partner Philips.
Author: Robert Lavine
DC Thompson makes Trax in $125m round
Retail data analytics provider Trax increased its overall funding to $235m in a DC Thompson-backed round that valued it at almost $1bn.
Jybd trucks in $46m
Trucking services platform Manbang Group put up the series A cash as part of a strategic partnership with the automotive services provider.
BitSight builds $60m series D
The risk management technology provider has closed a Singtel Innov8-backed round that increased its total funding to $155m.
Corporates get in Bind for $70m round
Health insurance platform Bind has raised funding from a consortium featuring strategic partner UnitedHealthcare and Ascension Ventures.
Tokyo Electric powers up new unit
Tepco Ventures will take the place of the power producer’s New Business Task Force and will focus on incubating new companies.
Parachute sets down with $30m
The home products producer will use the proceeds from the Grace Beauty Capital-backed series C round to expand its range and open more stores.
Puppet pops up with $42m
The software automation platform has now raised $127m in funding in total, raising cash in a Cisco Investments-led round that included VMware.
Forty Seven fetches $112m in IPO
The GV-backed cancer drug developer floated at the top of its range in an offering that could reach $129m.
I-Mab imports $220m in series C round
Tasly Pharmaceuticals contributed to a series C round for the immunotherapy developer, a year after backing its $150m series B.
Telstra and HarbourVest ring in $500m fund
Corporate venturing unit Telstra Ventures has transferred its assets into a partnership with HarbourVest reportedly sized at $500m.
Pinduoduo pursues billion-dollar IPO
The Tencent-backed group buying platform has filed to list in the US having raised almost $2.4bn in funding over the past year.
Noodle.ai threads its way to $35m
The enterprise AI software startup increased its overall funding to $51m in a Dell Technologies Capital-led series B round.
HaploX hacks series B
The SoftBank-backed genetic liquid biopsy technology developer has raised a nine-figure renminbi amount in a Shenzhen Capital-led round.